AzTrials
AzTrials

Blood Drawing ProcedureNCT03277092

Near Infrared Light in Paediatric Blood Drawing Centre

A study testing VeinViewer® in people with Blood Drawing Procedure, run by IRCCS Burlo Garofolo at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Reaching a peripheral venous access or making a blood sample in a scared infant or toddler can be challenging even for experienced nurses o pediatricians. Up to 60% of children report pain and distress during venipuncture and multiple attempts can result in more difficult physical and emotional conditions for… Read more about this study

Who is it for?
Ages Up to 18 years
Conditions the study is for
Blood Drawing Procedure
What is being tested?
VeinViewer®
Could I receive a placebo?
No, everyone receives an active treatment
How many people
115 participants
Where
1 siteItaly
Study dates
2 Oct 2017to 28 Nov 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • subjects accessing the outpatient blood-drawing service

Who cannot join

  • application of topical anaesthetic cream

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • IRCCS Burlo Garofolo

    Trieste, 34137

Other trials in Italy

About this study

Official title: Impact of Near Infrared Light in Paediatric Blood Drawing Centre on Rate of First Attempt Success and Time of Procedure

Reaching a peripheral venous access or making a blood sample in a scared infant or toddler can be challenging even for experienced nurses o pediatricians. Up to 60% of children report pain and distress during venipuncture and multiple attempts can result in more difficult physical and emotional conditions for subsequent insertions so that the procedure should be performed with the less number of punctures as possible. In about one third of children, more than one attempt is required to achieve peripheral intravenous cannulation. In the last years, specific tools have been developed to enhance the success in venipuncture or incannulation. Near-infrared (NIR) technology consists on light-emitting diodes placed underneath the hand, that makes vessels visible by projecting the processed image in a green light directly on to the puncture site. According to previous studies, NIR had shown a trend in reduction of time employed for a blood sample, in children younger of 6 yr.

The aim of this trial is to investigate if the use of the VeinViewer® in a pediatric blood drawing center could decrease time spent to perform the procedure and improve the rate of first attempt success.

Being tested
VeinViewer®, Usual care
Keywords
Child, blood drawing procedure, near Infrared light

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VeinViewer®Device

    Near-infrared (NIR) technology consists on light-emitting diodes placed underneath the hand, that makes vessels visible by projecting the processed image in a green light directly on to the puncture site

  • Usual careProcedure or surgery

    The blood drawing is performed traditionally

Study groups in NCT03277092
Study groupRoleWhat they receive
VeinViewer® groupExperimentalUse of near infrared light to perform blood draw (VeinViewer®)
Receives: Device: VeinViewer®
Usual care groupActive comparatorBlood drawing performed traditionally
Receives: Procedure: Usual care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to perform the procedure

    In seconds, from the placement of the tourniquet until the blood flows in the needle

    Measured: Intraprocedural

Secondary outcomes (1)
  1. Success at first attempt

    Percentage of success at first attempt

    Measured: Intraprocedural

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Sep 2017
  2. Study start2 Oct 2017
  3. Primary completion28 Nov 2017
  4. Study completion28 Nov 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
115 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03277092
Sponsor's protocol ID
RC 22/17
Status last verified
Jun 2017
First submitted
7 Sep 2017
Last updated
30 Nov 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Conversano E, Cozzi G, Pavan M, Minute M, Gortan E, Montico M, Vecchi Brumatti L, Ronfani L, Barbi E. Impact of near infrared light in pediatric blood drawing Centre on rate of first attempt success and time of procedure. Ital J Pediatr. 2018 May 25;44(1):60. doi: 10.1186/s13052-018-0501-1.

    PubMed 29801519

Questions about this trial

What is this clinical trial studying?

A study testing VeinViewer® in people with Blood Drawing Procedure, run by IRCCS Burlo Garofolo at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Nov 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to perform the procedure (time frame: Intraprocedural). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03277092, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Nov 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in